GLP-1 receptor agonism slows gastric emptying, which can increase intra-gastric pressure and promote acid reflux in susceptible individuals
The biology and pharmacology of GLP-1 GLP-1 is a major peptide hormone of the incretin system
Similarly, it is now possible to perform spatially-differentiated multi-omic tissue profiling, such that the content of DNA, production of transcripts, and expression of proteins thus discovered can be differentiated according to precise cellular, or even sub-cellular, origin
In addition, in order for these drugs to become a public health tool for cancer treatment or prevention, more information would be necessary such as what cancers are most affected by GLP-1s, how long patients need to remain on therapy for the desired protection and whether benefits differ between different GLP-1 medications
Insurance and prior authorization Insurance coverage for retatrutide is not currently available through ordinary prescription-benefit channels because retatrutide is not FDA-approved for any indication